The fate of chemoresistance in triple negative breast cancer (TNBC)
Elma A. O’Reilly , Luke Gubbins , Shiva Sharma , Riona Tully
BBA clinical 3 257 -275
351
2015
Blocking HDAC3 in Bone Marrow Stromal Cells Has Direct Anti-Multiple Myeloma Effect and Modulates T Cell Function
Yu-Tzu Tai , Paul Dowling , Takeshi Harada , Kenneth Wen
Blood 130 4429 -4429
2
2017
Novel Mechanisms Underlying IMiDs Resistance in Multiple Myeloma: Therapeutic Implications
Teru Hideshima , Kenneth C Anderson , Yu-Tzu Tai , Kenneth Wen
Blood 130 594 -594
2017
Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China.
Tian Dong , Ting Niu , Yan Li , Yunfan Yang
Journal of Cancer 12 ( 9) 2633 -2642
2021
CLO21-016: Incidence, Risk Factors, and Prognostic Implications of Peri-Transplant Orthostatic Hypotension in Patients With Multiple Myeloma
Robert Schlossman , Brett Glotzbecker , Giada Bianchi , Jacob Laubach
Journal of The National Comprehensive Cancer Network 19
2021
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
Tianzeng Chen , Gulden Camci-Unal , Irene M. Ghobrial , Tomasz Sewastianik
Blood Cancer Discovery
2021
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
Tianzeng Chen , Gulden Camci-Unal , Irene M. Ghobrial , Tomasz Sewastianik
Blood Cancer Discovery
2021
Dysregulated Translational Control Is a Central Feature of MM Mediated By 14-3-3ε Interactome Promoting Multiple Myeloma Cell Growth and Viability
Yan Xu , Mariateresa Fulciniti , Matthew Ho , Mehmet Kemal Samur
Blood 132 3176 -3176
2018
Anti-Tumor Activities of XBP1 Antigen-Specific Cytotoxic T Lymphocytes Are Enhanced By HDAC6 Inhibitor ACY241
Jooeun Bae , Matthew Ho , Brandon Nguyen , Arghya Ray
Blood 128 ( 22) 2143 -2143
2016
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma.
Yan Xu , Mariateresa Fulciniti , Mehmet K. Samur , Matthew Ho
Blood 136 ( 4) 468 -479
2
2020
Exploiting autophagy in multiple myeloma
Matthew Ho , Ashish Patel , Cathal Hanley , Adam Murphy
Journal of Cancer Metastasis and Treatment 2019
2
2019
A genome-scale CRISPR-Cas9 screening in myeloma cells identifies regulators of immunomodulatory drug sensitivity
Jiye Liu , Tianyu Song , Wenrong Zhou , Lijie Xing
Leukemia 33 ( 1) 171 -180
59
2019
Targeting histone deacetylase 3 (HDAC3) in the bone marrow microenvironment inhibits multiple myeloma proliferation by modulating exosomes and IL-6 trans-signaling.
Matthew Ho , Tianzeng Chen , Jiye Liu , Paul Dowling
Leukemia 34 ( 1) 196 -209
14
2020
Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
Matthew Ho , Ashish Patel , Chia Yin Goh , Maria Moscvin
Leukemia 34 ( 12) 3111 -3125
46
2020
Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?
Chia Yin Goh , Cathy Wyse , Matthew Ho , Ellen O'Beirne
Cancer Letters 473 90 -97
39
2020
Ywhae/14-3-3ε Expression Promotes Translation Initiation and Protein Synthesis in Multiple Myeloma Regulating Proteasome Load and Contributing to Proteasome Inhibitor Sensitivity/Resistance
Yan Xu , Matthew Ho , Mehmet Kemal Samur , Kenneth Wen
Blood 134 5539 -5539
2019
The Transmembrane Receptor Roundabout 1 (ROBO1) Is Necessary for Multiple Myeloma Proliferation and Homing to the Bone Marrow Niche
Giada Bianchi , Peter G. Czarnecki , Matthew Ho , Aldo M. Roccaro
Blood 134 507 -507
2019
Proteomics-inspired precision medicine for treating and understanding multiple myeloma
Matthew Ho , Giada Bianchi , Kenneth C. Anderson
Expert Review of Precision Medicine and Drug Development 5 ( 2) 67 -85
1
2020
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.
Yan Xu , Shuhui Deng , Xuehan Mao , Gang An
Clinical Lymphoma, Myeloma & Leukemia 18 ( 6) 422 -430
5
2018
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
Tengteng Yu , Yan Xu , Gang An , Yu-Tzu Tai
Clinical Lymphoma, Myeloma & Leukemia 20 ( 10)
2020